Valentina Casadio
Biosciences Laboratory
Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS
Valentina Casadio has not added Biography.
If you are Valentina Casadio and would like to personalize this page please email our Author Liaison for assistance.
The current role of telomerase in the diagnosis of bladder cancer.
Indian journal of urology : IJU : journal of the Urological Society of India Jan, 2009 | Pubmed ID: 19468427
Accuracy of urine telomerase activity to detect bladder cancer in symptomatic patients.
The International journal of biological markers Oct-Dec, 2009 | Pubmed ID: 20082275
Urinary biomarkers of non-muscle-invasive bladder cancer: current status and future potential.
Expert review of anticancer therapy Jun, 2012 | Pubmed ID: 22716491
Urine cell-free DNA integrity as a marker for early bladder cancer diagnosis: preliminary data.
Urologic oncology Nov, 2013 | Pubmed ID: 23141783
Urine cell-free DNA integrity as a marker for early prostate cancer diagnosis: a pilot study.
BioMed research international , 2013 | Pubmed ID: 23509700
Gene methylation in rectal cancer: predictive marker of response to chemoradiotherapy?
Journal of cellular physiology Dec, 2013 | Pubmed ID: 23702823
DNA Methylation profiles as predictors of recurrence in non muscle invasive bladder cancer: an MS-MLPA approach.
Journal of experimental & clinical cancer research : CR Nov, 2013 | Pubmed ID: 24252461
Prolonged exposure to (R)-bicalutamide generates a LNCaP subclone with alteration of mitochondrial genome.
Molecular and cellular endocrinology Jan, 2014 | Pubmed ID: 24397920
Assessment of DNA damage and telomerase activity in exfoliated urinary cells as sensitive and noninvasive biomarkers for early diagnosis of bladder cancer in ex-workers of a rubber tyres industry.
BioMed research international , 2014 | Pubmed ID: 24877087
Copy number analysis of 24 oncogenes: MDM4 identified as a putative marker for low recurrence risk in non muscle invasive bladder cancer.
International journal of molecular sciences Jul, 2014 | Pubmed ID: 25026175
Urine Cell-Free DNA Integrity Analysis for Early Detection of Prostate Cancer Patients.
Disease markers , 2015 | Pubmed ID: 26412928
Plasma AR and abiraterone-resistant prostate cancer.
Science translational medicine Nov, 2015 | Pubmed ID: 26537258
CYP17A1 polymorphisms and clinical outcome of castration-resistant prostate cancer patients treated with abiraterone.
The International journal of biological markers Jul, 2016 | Pubmed ID: 26954071
Circulating AR copy number and outcome to enzalutamide in docetaxel-treated metastatic castration-resistant prostate cancer.
Oncotarget Jun, 2016 | Pubmed ID: 27191887
Methylation pattern analysis in prostate cancer tissue: identification of biomarkers using an MS-MLPA approach.
Journal of translational medicine Aug, 2016 | Pubmed ID: 27576364
GSTP1 Methylation and Protein Expression in Prostate Cancer: Diagnostic Implications.
Disease markers , 2016 | Pubmed ID: 27594734
The potential use of urine cell free DNA as a marker for cancer.
Expert review of molecular diagnostics Dec, 2016 | Pubmed ID: 27796148
Cell-free DNA as a diagnostic marker for cancer: current insights.
OncoTargets and therapy , 2016 | Pubmed ID: 27822059
Vitamin D status among long-term survivors of testicular cancer.
Oncotarget Dec, 2016 | Pubmed ID: 28030821
Cell-free DNA detected by "liquid biopsy" as a potential prognostic biomarker in early breast cancer.
Oncotarget Mar, 2017 | Pubmed ID: 28186965
Urinary RNA-based biomarkers for prostate cancer detection.
Clinica chimica acta; international journal of clinical chemistry Oct, 2017 | Pubmed ID: 28807541
ABOUT JoVE
Copyright © 2024 MyJoVE Corporation. All rights reserved